Co-administration of pethidine 0.75 mg kg" 1 and clonidine 75 ug intrathecally provided good intraoperative anaesthesia for total hip replacement, similar to that obtained using 0.5% isobaric bupivacaine. Sensory and motor block were of shorter duration than that after 0.5% isobaric bupivacaine and 0.5% isobaric bupivacaine with morphine 0.5 mg (P < 0.001 sensory block, P < 0.001 motor block). Postoperative morphine consumption, measured using a patient-controlled system, was similar to that in patients in the bupivacaine only group (pethidine-clonidine: median 39mg/24h; bupivacaine: median 34 mg/24 h) but greater than that in the bupivacaine-morphine group (median 8 mg/24 h) (P < 0.001). Visual analogue pain scores after operation were similar to those with bupivacaine alone at all but one of the recording times but were greater than those in patients who received bupivacaine and morphine at 4, 6 and 10 h after operation (P < 0.001, P < 0.04, P < 0.02). The combination did not offer any major advantage over conventional agents. (Br. J. Anaesth. 1994; 73: 628-633) 
For lower abdominal or lower limb surgery, it has been common practice to administer an opioid with a local anaesthetic drug when performing intrathecal block to provide anaesthesia and postoperative analgesia. Local anaesthetics stabilize neuronal membranes whereas opioids are thought to inhibit neuronal excitation within the spinal cord itself.
Pethidine possesses local anaesthetic properties [1] in addition to opioid activity and several studies have examined its usefulness as a sole intrathecal anaesthetic [2] [3] [4] [5] [6] [7] . Doses used have ranged from 0.5 to 1.0 mg kg" 1 to a fixed 100-mg dose [3] [4] [5] [6] . The limited duration of sensory block sufficient for surgery has restricted clinical use to relatively short procedures such as inguinal hernia repair, perineal surgery and transurethral resection of the prostate. However, intrathecal pethidine may offer an inexpensive alternative to conventional methods of providing intraoperative anaesthesia and postoperative analgesia for lower limb operations. Clonidine, an agonist at a adrenoreceptors, given intrathecally has been shown to prolong the block produced by local anaesthetic agents [8, 9] .
We decided to determine if the addition of clonidine to pethidine prolonged the local anaesthetic effect of intrathecal pethidine and potentiated opioid receptor-mediated analgesia, by comparing intrathecal block and postoperative analgesia in patients undergoing total hip replacement after co-administration of pethidine and clonidine intrathecally and after intrathecal administration of 0.5 % isobaric bupivacaine with and without morphine.
Patients and methods
The study was approved by the University Research Ethics Committee and patients gave informed written consent. We studied 90 patients, ASA I and II, aged 18-80 yr, whose weights were within 20% of their ideal weight, undergoing hip replacement. Patients were excluded if there was a contraindication to regional anaesthesia, allergy to opioids, a history of hepatic or renal impairment, or a history of treatment with drugs other than simple oral analgesics.
At the preoperative visit, patients were instructed in the recording of pain and nausea after operation using a 10-cm visual analogue scale. They were familiarized with the use of a patient-controlled analgesia system (PGA, Abbott Lifecare 4200). All patients received temazepam 20 mg orally 90 min before operation.
Before anaesthesia an i. v. infusion was commenced. With the patient in the lateral decubitus position with the affected hip uppermost, dural puncture was performed at the L2-3 or L3-4 intervertebral space using a 25-gauge pencil-point spinal needle. Drugs were injected over 10 s without barbotage.
Before operation patients were allocated randomly (by closed envelope technique) to one of three groups: group B received bupivacaine 13.75 mg (0.5% isobaric bupivacaine 2.75 ml) and 0.9% sodium chloride 1 ml; group BM received bupivacaine 13.75 mg (0.5% isobaric bupivacaine 2.75 ml), preservative-free morphine sulphate 0.5 mg (0.25 ml) and 0.9 % sodium chloride 0.75 ml; group PC received preservative-free pethidine 0.75 mg kg" 1 and clonidine 75 ug (0.5 ml) made up to a total volume of 3.75 ml with 0.9 % sodium chloride. Analgesic drugs were drawn up by an anaesthetist who took no further part in the study. Patients, recovery ward nurses, nurse observers and the investigator (D.G.) were unaware of the patient's group.
During and after operation, heart rate, electrocardiogram, ventilatory frequency, .Spo, and arterial pressure (by electronic oscillotonometer) were monitored. Intraoperative blood loss was determined by weighing of swabs and measurement of losses in suction bottles, and after operation by measurement of losses into the drains. Oxygen 5 litre min" 1 was given during operation by Hudson mask. I.v. fluid therapy consisted of Dextran 70 0.5 litre followed by Hartmann's solution 250 ml h~' during operation and 0.18 % sodium chloride in 4 % glucose 100 ml h~' after operation. Blood was transfused when blood loss exceeded 15 % of the patient's estimated circulating blood volume. Ephedrine 5 mg was given i.v. if there was a 30 % reduction in mean arterial pressure from the value obtained before induction of intrathecal anaesthesia.
During operation patients were sedated with propofol 3mgkg" 1 h" 1 . Prochlorperazine 12.5 mg was given i.m. as antiemetic prophylaxis and all patients had a bladder catheter passed, as is standard practice in our unit. After intrathecal injection, sensory block (to ice) and motor block (modified Bromage scale [10] ) were assessed at 2 and 5 min and then at 5-min intervals until a constant block was obtained and at 15-min intervals after operation until there was regression of sensory block to the fifth lumbar dermatome and return of full motor function.
After operation PCA was provided with bolus doses of morphine 1 mg and a lock-out interval of 5 min. Additional morphine 2.5 mg could be given by recovery ward staff if required. Time to first PCA demand (timed from administration of intrathecal drugs), total number of PCA demands and the ratio of successful to unsuccessful attempts, in addition to supplementary analgesic requirements, were recorded.
Patients completed VAS scales for pain and nausea at rest, at 30 min and at 1, 2, 4, 6, 8, 10, 12 and 24 h. Emetic episodes and the use of antiemetics were recorded as were the incidences of pruritus and respiratory depression.
Patients were nursed after operation in the surgical high dependency unit (HDU). A regimen for management of adverse events accompanied patients to the HDU.
Parametric data were analysed using, where appropriate, analysis of variance (ANOVA) and post hoc analysis (Newman-Keuls). Non-parametric data were analysed using Kruskal-Wallis ANOVA and Mann-Whitney U test. Differences in the incidences of adverse events and in the numbers of patients recording pain scores at 0 cm or as less than 3 cm were analysed using chi-square and Fisher's exact probability tests. Statistical significance was assumed at the 5 % level of probability.
Results
Patient characteristics are shown in table 1 and details of local anaesthetic block in the three groups are given in table 2. Times to maximum levels of sensory block were similar in the three groups. Extension of block was greatest in patients receiving bupivacaine and morphine (fourth thoracic dermatome). Time to maximum motor block was shortest in group BM (median 10 min) compared with group PC (15 min) (P < 0.004) and group B (15 min) (P < 0.02). Time to two segment regression of block was shortest in group PC patients (120 min) but this was not significantly different from that in the two other groups. Times to regression of sensory block to the fifth lumbar dermatome and to return of full motor function were significantly shorter in group PC patients (sensory block median 285 min, motor block median 180 min) than in groups B (sensory block 360 min, motor block 330 min) (P < 0.001) and BM (sensory block 420 min, motor block 345 min) (P < 0.001). No patient complained of pain or moved in response to surgery and anaesthesia, and operating conditions were considered satisfactory in all patients. In the pethidine-clonidine group, the mean dose of pethidine given intrathecally was 56 (SD 9) mg.
Postoperative analgesia, as assessed by PCA request, was similar for patients in groups B and PC but significantly better for group BM (table 3) . The times to first PCA demand were similar in groups PC (median 245 min) and B (219 min) but were significantly longer for group BM (446 min) (P < 0.001). In group BM, patients made significantly fewer PCA demands (median 11 demands) (P < 0.001) than patients in groups B (81 demands) and PC (94 demands), who made similar numbers of demands. The ratio of total to successful demands and hourly morphine consumption were significantly less in group BM patients (ratio 1.3, median consumption 0.4 mg h"') (P < 0.001) and again were similar in groups B (ratio 2.1, median consumption 1.6 mg h~') and PC (ratio 2.8, median consumption 1.9 mg h" 1 ). Five patients in group BM made no PCA demands and requested no additional analgesia whereas all patients in groups B and PC made PCA demands (P < 0.02). Significantly fewer patients in group BM (one patient) requested additional i.v. analgesia compared with groups B (11 patients) and PC (12 patients) (P < 0.001). The total dose of additional analgesic obtained was similar in the groups. VAS pain scores were low in patients in all groups at all recording times (table 4). At 2, 4, and 6 h after operation pain scores were significantly less in group BM patients than in those in group B (P < 0.04, P < 0.02, P < 0.02). Pain scores were also significantly less in group BM patients than group PC at 4 and 6 h after operation (P < 0.01, P < 0.04). At 10 h after operation, pain scores were significantly greater in group PC patients than in patients in both group B (P < 0.05) and group BM (P < 0.02). The number of patients recording pain as 0 cm, or as less than 3 cm was significantly greater in group BM compared with both groups B and PC at 2,4 and 6 h after operation and significantly greater in group BM than in group PC alone at 8 h (table 5 ). In addition, at 4, 10 and 12 h after operation, the number of patients recording pain as 0 cm or as less than 3 cm was significantly greater in both groups BM and B compared with group PC.
Mean arterial pressure (calculated as diastolic pressure and one-third of pulse pressure) decreased significantly in all groups from preoperative values and was significantly lower at 45, 60, 75, 90, 105, 120, 180 and 240 min after intrathecal injection in patients in group PC compared with patients in the 96 (17) 71 (13) 69 (11) 72 (14) 79 (14) 88 (14) 89 (11) 88 (17) Group BM (n = 30) 100 (18) 73 (15) 71 (12) 73 (14) 73 (11) 80 (12) 82 (11) 81 (13) Group PC (n = 30) 100 (13) 62 (12) 60 (9) 59 (9) 64 (13) 68 (10) 71 (10) 74 (10 i.v. fluids were similar in the three groups. Significantly more patients in group PC than in either of the two other groups required ephedrine to treat hypotension (P < 0.001) (table 7) and in those patients receiving ephedrine the dose was significantly greater in group PC than in group B (P < 0.002) and group BM (P < 0.001). Patients in group PC received significantly more colloid than patients in group BM (P < 0.02).
The groups had similar incidences of nausea, vomiting and antiemetic administration, and pruritus (table 8) . In one patient only (in group BM) ventilatory frequency decreased briefly to 8 b.p.m. In this patient peripheral oxygen saturation remained high (98 %) with 28 % oxygen delivered by Hudson face mask and ventilatory frequency increased shortly afterwards (to 12 b.p.m.) without treatment.
Discussion
We have shown that co-administration of pethidine 0.75 mg kg" 1 and clonidine 75 |ig provided acceptable anaesthesia for total hip replacement.
The use of intrathecally administered drugs to provide analgesia is well established. Opioids are most commonly used [11, 12] providing both effective and prolonged analgesia. Both endogenous and exogenous opioids act at receptors located in the substantia gelatinosa in the dorsal horn [13, 14] but additional mechanisms are involved in spinal antinociception. a 2 Adrenoreceptors and calcitonin, adenosine and somatostatin have been shown to mediate antinociception spinally [15] [16] [17] [18] . The a 2 adrenergic agonists produce analgesia by mimicking the postsynaptic actions of noradrenaline released from bulbospinal pathways [18] [19] [20] . a 2 Adrenergic receptors are located both pre-and postsynaptically in small primary afferents in the dorsal horn. Local administration of a 2 agonists depresses the activity of wide dynamic range neurones in the dorsal horn [18] and reduces the release of substance P [17] .
Clonidine has been previously demonstrated [8, 9 ] to prolong local anaesthetic action. This occurs also with adrenaline and appears to result from impaired systemic absorption of local anaesthetic; however, this does not appear to be the case with clonidine [21] . Local anaesthetics inhibit propagation of the action potential by blocking sodium channels [22] . Clonidine opens potassium channels possibly reducing neurotransmitter release from presynaptic sites on primary afferents and shortening action potential duration [22] . Furthermore, it raises thermal, mechanical and chemical nociceptive thresholds [23] . These actions may complement the actions of local anaesthetics in stabilizing neurones and account for local anaesthetic enhancement.
Clonidine, an agonist at a adrenergic receptors in the central nervous system [24, 25] and in the peripheral vasculature [26] , has been given by the extradural [27, 28] and intrathecal [9, 10] routes in an attempt to augment postoperative analgesia. After extradural administration, clinically useful analgesia was obtained [27, 28] . After intrathecal administration the time to first PGA morphine demand was prolonged by clonidine (to 6 h) compared with control (0.9% sodium chloride) (2.5 h). Overall analgesia and PCA morphine consumption were similar [9] . Problems associated with its use have been hypotension, sedation and dry mouth.
The cardiovascular actions of clonidine are complex. It acts at the nucleus tractus solitarius in the medulla [29] to reduce sympathetic outflow, thereby reducing heart rate and arterial pressure. In the peripheries, activity at presynaptic a 2 receptors causes vasodilatation while activity at postsynaptic a 2 receptors and at peripheral o^ receptors produces vasoconstriction. Hypotension after intrathecal administration of clonidine may be mediated at a 2 adrenergic receptors within the spinal cord [20] .
In this study good postoperative analgesia was obtained in all groups. VAS pain scores and PCA morphine consumption were least in patients given bupivacaine and morphine. Postoperative analgesia was poorer after spinal block with pethidineclonidine than with bupivacaine alone, possibly reflecting perhaps the shorter duration of sensory block. Cousins and co-workers produced prolonged analgesia in patients with cancer pain after intrathecal injection of pethidine 10-30 mg [31] . Our results suggest that after an intrathecal dose of 0.75 mg kg" 1 the local anaesthetic and opioid receptor-mediated analgesic properties of pethidine are short-lived in patients after total hip replacement. This is in contrast with the findings of Fawero and Naquib [2] and Tauzin-Fin and colleagues [7] who reported prolonged postoperative analgesia after high-dose intrathecal pethidine in patients after perineal and prostatic surgery. They attributed the analgesia to activity at opioid receptors in the spinal cord as measured plasma concentrations of pethidine were considerably less than minimum effective analgesic plasma concentrations after i.v. administration. Postoperative pain after these procedures is, however, considerably less than that associated with total hip replacement. Acalovschi and colleagues reported postoperative analgesia (taken as time to first analgesic request) of 5 h in patients undergoing perineal surgery [3] , a duration similar to that in this study (mean time to first PCA demand 245 min in group PC patients).
Despite the relatively high dose of pethidine used, respiratory depression (ventilatory frequency < 8 b.p.m.) did not occur in any patient in the pethidine-clonidine group. The high lipid solubility of pethidine implies that cephalic spread in the cerebrospinal fluid is unlikely [32] , although not necessarily impossible, and we would recommend that after intrathecal administration, patients should remain overnight in a HDU. In summary, we found that the combination of pethidine and clonidine administered intrathecally produced acceptable anaesthesia of adequate duration for total hip replacement. Anaesthesia was comparable in quality with that obtained with a conventional isobaric bupivacaine technique. The technique was associated with greater hypotension than that produced by standard anaesthetic techniques. Postoperative analgesia was similar to that obtained with 0.5 % bupivacaine alone but inferior to that obtained with a 0.5 % bupivacainemorphine technique. The incidence of side effects (nausea, vomiting, pruritus) did not differ between the groups. The greater incidence of hypotension and the lack of additional analgesia compared with a conventional isobaric bupivacaine technique suggest that the technique is not indicated for routine use. It may, however, prove a useful technique on the rare occasion when a patient with a history of allergy to local anaesthetic agents presents for surgery.
